UK Medical Student Earns First-Place in ACS Research Program

Posted: 10/27/2020
A research abstract from Jacob Hubbuch, a third-year student from the University of Kentucky College of Medicine, was awarded first place in the Education, Innovation, and Outcomes category of the American College of Surgeons’ (ACS) Medical Student Research Program. The research was among three top finishers featured at the ACS 2020 Virtual Clinical Congress on Oct. 3.Hubbuch’s abstract, Ventral Hernia Repair with Soft Tissue Excision Impacts Costs and Outcomes, was selected from over 200 submissions for consideration. It was a record number of submissions, said Brad DeFabo Akin, educational programs administrator in ACS’ Division of Education. Under normal... FULL STORY

Multi-Million Dollar Multidisciplinary Grant Supports Advancement of

Posted: 10/27/2020
LEXINGTON, KY. (Oct. 27, 2020) — A $2.9 million grant from the National Institutes of Health (NIH) is supporting a multidisciplinary team of University of Kentucky researchers in continuing their work to find therapeutic strategies to resolve neurovascular inflammation and repair blood-brain barrier dysfunction in epilepsy.Bjoern Bauer, Ph.D., associate professor, College of Pharmacy, is the principal investigator. A group of researchers from Sanders-Brown Center on Aging are co-investigators, including Anika Hartz, Ph.D., associate professor, College of Medicine; Dick Kryscio, Ph.D., professor, College of Arts & Sciences; and Ai-... FULL STORY

Dr. Matthew Bush Highlights Positive Experience in UK College of Medicine

Posted: 10/19/2020
Matthew Bush, MD, PhD, MBA, is an experienced clinician, academic leader, and researcher. While he has been directly involved in health care and academia throughout his career, he credits the progress of his research career to a program he completed at the University of Kentucky College of Medicine while serving as a faculty member.One of Dr. Bush’s biggest career objectives when he joined UK in 2011 was to expand the breadth and impact of research within his department and within his field. As a clinician he knew he needed to receive more training to grow as a researcher because medical training by itself doesn’t always offer rigorous, immersive training in clinical... FULL STORY
Tags: Department of Behavioral Science

Register for the 10th Annual Markesbery Symposium

Posted: 10/19/2020
The UK Sanders-Brown Center on Aging, a world leader in Alzheimer's research and community outreach, will hold its 10th annual Markesbery Symposium. There will be a community session and scientific session, each held via Zoom.Community SessionKeynote:Maria Carrillo, PhDChief Scientific Officer, National Alzheimer's AssociationSaturday, Oct. 31, 20209:55 a.m. - 12:30 p.m.Register Here Scientific SessionKeynote:Alison Goate, DPhilDirector, The Ronald M. Loeb Center for Alzheimer's DiseaseMonday, Nov. 9, 20209:50 a.m. - 2 p.m.Register Here
Tags: UK Sanders-Brown Center on Aging

Dr. Jeffrey Selby Named Chair of Orthopaedic Surgery and Sports Medicine

Posted: 10/12/2020
After dedicating more than two years as interim chair of orthopaedic surgery and sports medicine, the University of Kentucky College of Medicine has officially named Jeffrey Selby, MD, chair of his department. The promotion took effect Oct. 1. Dr. Selby has been a devoted physician and educator since joining the University of Kentucky as a faculty member in 2002 after graduating from the UK College of Medicine’s orthopaedic surgery residency program. Dr. Selby possesses abundant knowledge in hip and knee replacement, orthopaedic trauma, and general orthopedic surgery, which has made him a key asset on our team as we focus on improving the health of Kentuckians... FULL STORY

Butterfield Recognized as a Leading Alzheimer’s Expert

Posted: 10/9/2020
LEXINGTON, Ky. (Oct. 9, 2020) — Allan Butterfield, a professor of biological chemistry in the University of Kentucky College of Arts & Sciences, has been named among the world’s leading Alzheimer’s disease experts by Expertscape, an online base of biomedical expertise.Butterfield is among the top 0.007% of scholars worldwide based on authorship of Alzheimer’s-related publications indexed in the PubMed database for the past 10 years. He ranks tenth out of nearly 150,000 scholars worldwide and sixth in the U.S.The Expertscape rankings use an algorithm to identify the most knowledgeable and experienced physicians, clinicians and researchers across more than 29... FULL STORY

UK College of Medicine Honors Henrietta Lacks’s Legacy

Posted: 10/5/2020
Henrietta Lacks’s “HeLa” cells continue to influence scientific discovery even after her death from cancer in 1951. These cells have been used to study cancer growth, learn more about viruses, and study drug effects on the body. They even helped develop the polio vaccine.While her impact in medicine is widespread, Lacks’s story also has sparked important ethics discussions because her cells were used for research without her permission. On Thursday, Oct. 1, the UK College of Medicine’s Students Embracing Equity in Medical Sciences (SEEMS) hosted “Black Lives Matter Immortalized: CELLebrating the Legacy of Henrietta Lacks.” The virtual event provided a forum for... FULL STORY
Tags: ODEI, henrietta lacks, research

New Study Looks at Encoding the Odor of Cigarette Smoke

Posted: 9/30/2020
LEXINGTON, Ky. (Sept. 30 2020) — A recent publication in the Journal of Neuroscience by a group of researchers at the University of Kentucky looks at Encoding the Odor of Cigarette Smoke. Tim McClintock, a physiology professor in the UK College of Medicine, says their work lays a foundation for two things.“One is basic knowledge of how we tell one smell from another. We call this odor discrimination," he said. "The other is blocking the detection of unwanted odors and cigarette smoke is an unwanted odor due to its general - though relatively mild – offensiveness, and for its clinical significance. The odor of cigarette smoke triggers the... FULL STORY

Virtual WIMS Day to Provide Networking, Career Development Opportunities

Posted: 9/28/2020
The UK College of Medicine’s Women in Medicine and Science (WIMS) will host its sixth annual Visiting Professor Program, also known as “WIMS Day,” this fall as a virtual program. The event will serve as an opportunity for faculty, staff, and learners to network, develop their career skills, and learn about the strides women have made in medicine and science.This will be the third WIMS Day organized by April Hatcher, PhD, associate professor of neuroscience, who was recently named chair of WIMS. Prior to her role as chair, Dr. Hatcher was co-chair of the program committee, along with Meera Gupta, MD, and contributed to regular professional development programming for the... FULL STORY
Tags: WIMS, WIMS Day

Sanders-Brown Research Discovers New Pathway in TDP-43 Related Dementias

Posted: 9/23/2020
LEXINGTON, Ky. (Sept. 23, 2020) – Recent work published by researchers at the University of Kentucky’s Sanders-Brown Center on Aging (SBCoA) highlights what the lead investigator calls the “cornerstone” of her lab. Maj-Linda Selenica, assistant professor at SBCoA, led the study recently published in BBA Molecular Basis of Disease. She says their approach was unconventional as it looked at the molecular mechanisms implicated in TDP-43 biology, which is the focus of her lab. TDP-43 is a DNA/RNA binding protein that has been found to be the hallmark pathology in a wide range of neurodegenerative diseases. Selenica says their study is the first to provide a novel pathway... FULL STORY

UK Study Highlights Need for Genetic Testing for Kentucky Patients with

Posted: 9/23/2020
LEXINGTON, Ky. (Sept. 23, 2020) – A study led by researchers at the University of Kentucky Markey Cancer Center highlighted differences in patient diagnosis and treatment in those with non-small cell lung cancer (NSCLC) across the state of Kentucky. Recently published in PLOS One, the study used Kentucky Cancer Registry patient data from 2007-2011 to identify trends in epidermal growth factor receptor (EGFR) mutation testing and the usage of the EGFR inhibitor, erlotinib. EGFR mutations are common in NSCLC. Studies cited in the article highlight the efficacy of using EGFR inhibitors, such as erlotinib, in improving patient outcomes. The relationship between... FULL STORY

Markey Joins National Cancer Consortium to Address the Impact of COVID-19

Posted: 9/22/2020
LEXINGTON, Ky. (Sept. 22, 2020) – The University of Kentucky Markey Cancer Center has joined a consortium of 17 cancer centers around the country to better understand the consequences of the COVID-19 pandemic as it relates to disrupted cancer prevention, detection and care.Coordinated by the O’Neal Comprehensive Cancer Center at the University of Alabama at Birmingham, the cancer centers are working together with funding from the National Cancer Institute to study the impact of the pandemic on the continuum of cancer care from prevention to survivorship. This work will further examine whether differences in demographics impact cancer prevention... FULL STORY